Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

被引：0

作者：

Chatzikonstantinou, Thomas ^{[1
]}

Scarfo, Lydia ^{[2
,3
]}

Minga, Eva ^{[1
]}

Karakatsoulis, Georgios ^{[1
]}

Chamou, Dimitra ^{[1
]}

Kotaskova, Jana ^{[4
,5
,6
]}

Iacoboni, Gloria ^{[7
]}

Demosthenous, Christos ^{[8
,9
]}

Albi, Elisa ^{[2
]}

Alcoceba, Miguel ^{[10
,11
]}

Al-Shemari, Salem ^{[12
]}

Aurran-Schleinitz, Therese ^{[13
]}

Bacchiarri, Francesca ^{[14
]}

Chatzileontiadou, Sofia ^{[15
]}

Collado, Rosa ^{[16
]}

Davis, Zadie ^{[17
]}

de Deus Santos, Marcos Daniel ^{[18
]}

Dimou, Maria ^{[19
]}

Dmitrieva, Elena ^{[20
]}

Donaldson, David ^{[21
]}

Dos Santos, Gimena ^{[22
]}

Dreta, Barbara ^{[23
]}

Efstathopoulou, Maria ^{[24
]}

El-Ashwah, Shaimaa ^{[25
]}

Enrico, Alicia ^{[26
]}

Frygier, Andrzej ^{[27
]}

Galimberti, Sara ^{[28
]}

Galitzia, Andrea ^{[29
]}

Gimeno, Eva ^{[30
]}

Guarente, Valerio ^{[31
,32
,33
]}

Guieze, Romain ^{[34
]}

Harrop, Sean ^{[35
]}

Hatzimichael, Eleftheria ^{[36
]}

Herishanu, Yair ^{[37
,38
]}

Hernandez-Rivas, Jose-angel ^{[39
]}

Jaksic, Ozren ^{[40
]}

Kalicinska, Elzbieta ^{[41
]}

Laribi, Kamel ^{[42
]}

Karakus, Volkan ^{[43
]}

Kater, Arnon P. ^{[44
]}

Kho, Bonnie ^{[45
]}

Kislova, Maria ^{[20
]}

Konstantinou, Eliana ^{[46
]}

Koren-Michowitz, Maya ^{[47
,48
]}

Kotsianidis, Ioannis ^{[49
]}

Kubova, Zuzana ^{[50
,51
]}

Labrador, Jorge ^{[52
]}

Lad, Deepesh ^{[53
]}

Laurenti, Luca ^{[54
,55
]}

Longval, Thomas ^{[56
]}

机构：

[1] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece

[2] Univ Vita Salute San Raffaele, Milan, Italy

[3] IRCCS Osped San Raffaele, Milan, Italy

[4] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic

[5] Masaryk Univ, Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic

[6] Masaryk Univ, Fac Med, Brno, Czech Republic

[7] Univ Hosp Vall dHebron, Dept Hematol, Barcelona, Spain

[8] G Papanicolaou Hosp, Hematol Dept, Thessaloniki, Greece

[9] G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece

[10] Univ Hosp Salamanca HUS IBSAL, Dept Haematol, CIBERONC CB16 12 00233, Salamanca, Spain

[11] Canc Res Ctr CIC IBMCC USAL CSIC, Salamanca, Spain

[12] Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait

[13] Inst Paoli Calmettes, Dept Hematooncol, Marseille, France

[14] Univ Siena, Div Hematol, Siena, Italy

[15] AUTH, AHEPA Hosp, Dept Internal Med 1, Hematol Unit, Thessaloniki, Greece

[16] Fdn Invest Hosp Gen Univ Valencia, Consorcio Hosp Gen Univ Valencia, Serv Hematol, Valencia, Spain

[17] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England

[18] Univ Fed Espirito St, Internal Med Dept, Vila Velha, ES, Brazil

[19] Natl & Kapodistrian Univ Athens, Laikon Gen Hosp, Dept Hematol & Bone Marrow Transplantat, Athens, Greece

[20] SP Botkins City Hosp, Dept Hematol Oncol & Chemotherapy, Moscow, Russia

[21] Belfast City Hosp, Clin Haematol, Belfast, North Ireland

[22] Hosp Clin Montevideo, Montevideo, Uruguay

[23] Univ Hosp Ctr Zagreb, Dept Internal Med, Div Hematol, Zagreb, Croatia

[24] Athens Med Ctr Psychikon Branch, Dept Haematol, Athens, Greece

[25] Mansoura Univ, Oncol Ctr, Mansoura, Egypt

[26] Hosp Italiano La Plata, La Plata, Buenos Aires, Argentina

[27] Hull York Med Sch, Kingston Upon Hull, England

[28] Univ Pisa, Dept Clin & Expt Med, Sect Hematol, Pisa, Italy

[29] Osped Oncol A Businco, ARNAS G Brotzu, Hematol & Stem Cell Transplantat Unit, Cagliari, Italy

[30] Hosp Mar, Dept Hematol, Barcelona, Spain

[31] Univ Perugia, Inst Hematol, Perugia, Italy

[32] Univ Perugia, Ctr Hematooncol Res, Perugia, Italy

[33] Santa Maria Misericordia Hosp, Perugia, Italy

[34] Estaing Univ Hosp, Dept Hematol & Cell Therapy, Clermont Ferrand, France

[35] Univ Melbourne, St Vincents Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[36] Univ Ioannina, Fac Med, Sch Hlth Sci, Dept Haematol, Ioannina, Greece

[37] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel

[38] Tel Aviv Univ, Fac Med, Tel Aviv, Israel

[39] Infanta Leonor Univ Hosp, Pathol Dept, Madrid, Spain

[40] Univ Hosp Dubrava, Dept Hematol, Zagreb, Croatia

[41] Wroclaw Med Univ, Dept & Clin Hematol Blood Neoplasms & Bone Marrow, Wroclaw, Poland

[42] Ctr Hosp Le Mans, Dept Hematol, Le Mans, France

[43] Antalya Training & Res Hosp, Antalya, Turkiye

[44] Univ Amsterdam, Amsterdam Univ Med Ctr, Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands

[45] Pamela Youde Nethersole Eastern Hosp, Dept Med, Chai Wan, Hong Kong, Peoples R China

[46] Univ Athens, Laikon Gen Hosp, Dept Haematol, Athens, Greece

[47] Shamir Med Ctr, Dept Hematol, Zerifin, Israel

[48] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel

[49] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Hematol, Alexandroupolis, Greece

[50] Palacky Univ, Fac Med & Dent, Dept Hematooncol, Olomouc, Czech Republic

来源：

HEMASPHERE | 2024年 / 8卷 / 09期

关键词：

VENETOCLAX; RITUXIMAB;

D O I：

10.1002/hem3.70004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：7

共 50 条

[1] Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL
Agathangelidis, Andreas
Chatzidimitriou, Anastasia
Chatzikonstantinou, Thomas
Tresoldi, Cristina
Davis, Zadie
Giudicelli, Veronique
Kossida, Sofia
Belessi, Chrysoula
Rosenquist, Richard
Ghia, Paolo
Langerak, Anton W.
Davi, Frederic
Stamatopoulos, Kostas
LEUKEMIA, 2022, 36 (08) : 1961 - 1968
[2] A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study
Rawstron, A. C.
Fazi, C.
Agathangelidis, A.
Villamor, N.
Letestu, R.
Nomdedeu, J.
Palacio, C.
Stehlikova, O.
Kreuzer, K-A
Liptrot, S.
O'Brien, D.
de Tute, R. M.
Marinov, I.
Hauwel, M.
Spacek, M.
Dobber, J.
Kater, A. P.
Gambell, P.
Soosapilla, A.
Lozanski, G.
Brachtl, G.
Lin, K.
Boysen, J.
Hanson, C.
Jorgensen, J. L.
Stetler-Stevenson, M.
Yuan, C.
Broome, H. E.
Rassenti, L.
Craig, F.
Delgado, J.
Moreno, C.
Bosch, F.
Egle, A.
Doubek, M.
Pospisilova, S.
Mulligan, S.
Westerman, D.
Sanders, C. M.
Emerson, R.
Robins, H. S.
Kirsch, I.
Shanafelt, T.
Pettitt, A.
Kipps, T. J.
Wierda, W. G.
Cymbalista, F.
Hallek, M.
Hillmen, P.
Montserrat, E.
LEUKEMIA, 2016, 30 (04) : 929 - 936
[3] Assay-guided treatment sequencing in chronic lymphocytic leukemia (CLL): a cost-effectiveness analysis
Pollard, Samantha
Chan, Brandon
Gerrie, Alina S.
Raymakers, Adam J. N.
Regier, Dean A.
SCIENTIFIC REPORTS, 2024, 14 (01):
[4] Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)
Quinquenel, Anne
Aurran-Schleinitz, Therese
Clavert, Aline
Cymbalista, Florence
Dartigeas, Caroline
Davi, Frederic
de Guibert, Sophie
Delmer, Alain
Dilhuydy, Marie-Sarah
Feugier, Pierre
Fornecker, Luc-Matthieu
Ghez, David
Guieze, Romain
Laribi, Kamel
Leblond, Veronique
Lepretre, Stephane
Letestu, Remi
Levy, Vincent
Nguyen-Khac, Florence
Michallet, Anne-Sophie
Tomowiak, Cecile
Tournilhac, Olivier
Ysebaert, Loic
Troussard, Xavier
HEMASPHERE, 2020, 4 (05): : E473
[5] Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL
Rawstron, A. C.
Boettcher, S.
Letestu, R.
Villamor, N.
Fazi, C.
Kartsios, H.
de Tute, R. M.
Shingles, J.
Ritgen, M.
Moreno, C.
Lin, K.
Pettitt, A. R.
Kneba, M.
Montserrat, E.
Cymbalista, F.
Hallek, M.
Hillmen, P.
Ghia, P.
LEUKEMIA, 2013, 27 (01) : 142 - 149
[6] Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia
Moreno, Carol
Montillo, Marco
Panayiotidis, Panayiotis
Dimou, Maria
Bloor, Adrian
Dupuis, Jehan
Schuh, Anna
Norin, Stefan
Geisler, Christian
Hillmen, Peter
Doubek, Michael
Trneny, Marek
Obrtlikova, Petra
Laurenti, Luca
Stilgenbauer, Stephan
Smolej, Lukas
Ghia, Paolo
Cymbalista, Florence
Jaeger, Ulrich
Stamatopoulos, Kostas
Stavroyianni, Niki
Carrington, Patrick
Zouabi, Hamadi
Leblond, Veronique
Gomez-Garcia, Juan C.
Rubio, Martin
Marasca, Roberto
Musuraca, Gerardo
Rigacci, Luigi
Farina, Lucia
Paolini, Rossella
Pospisilova, Sarka
Kimby, Eva
Bradley, Colm
Montserrat, Emili
HAEMATOLOGICA, 2015, 100 (04) : 514 - 519
[7] Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study
Goede, V.
Fischer, K.
Engelke, A.
Schlag, R.
Lepretre, S.
Montero, L. F. C.
Montillo, M.
Fegan, C.
Asikanius, E.
Humphrey, K.
Fingerle-Rowson, G.
Hallek, M.
LEUKEMIA, 2015, 29 (07) : 1602 - 1604
[8] Treatment with idelalisib in patients with chronic lymphocytic leukemia - real world data from the registry of the German CLL Study Group
von Tresckow, Julia
Heyl, Nikola
Robrecht, Sandra
Giza, Adam
Aldaoud, Ali
Schlag, Rudolf
Klausmann, Martine
Linde, Hartmut
Stein, Wolfgang
Schwarzer, Andreas
Fischer, Kirsten
Cramer, Paula
Eichhorst, Barbara
Hallek, Michael
Fink, Anna Maria
ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3083 - 3090
[9] A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)
Chen, Christine I.
Paul, Harminder
Snitzler, Susi
Kakar, Sumeet
Le, Lisa W.
Wei, Ellen N.
Lau, Anthea
Johnston, James B.
Gibson, Spencer B.
Queau, Michelle
Spaner, David
Croucher, Danielle
Sherry, Barbara
Trudel, Suzanne
LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 980 - 989
[10] Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group
Goede, Valentin
Bahlo, Jasmin
Chataline, Viktoria
Eichhorst, Barbara
Duerig, Jan
Stilgenbauer, Stephan
Kolb, Gerald
Honecker, Friedemann
Wedding, Ulrich
Hallek, Michael
LEUKEMIA & LYMPHOMA, 2016, 57 (04) : 789 - 796

← 1 2 3 4 5 →